Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022)

Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022)

(1) Background: With the massive demand for the use and commercialization of medicinal cannabidiol (CBD) products, new randomized clinical trials (RCTs) are being published worldwide, with a constant need for safety and efficacy evaluation. (2) Methods: We performed an update on a systematic review...

Full description

Bibliographic Details
Main Authors: José Diogo R. Souza, Julia Cozar Pacheco, Giordano Novak Rossi, Bruno O. de-Paulo, Antonio W. Zuardi, Francisco S. Guimarães, Jaime E. C. Hallak, José Alexandre Crippa, Rafael G. Dos Santos
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pharmaceutics
Subjects:
cannabidiol
CBD
safety
adverse effects
drug interaction
Online Access:https://www.mdpi.com/1999-4923/14/12/2598

Internet

https://www.mdpi.com/1999-4923/14/12/2598

Similar Items